- Home
- FTAIM vs FBIO Comparison
FTAIM vs FBIO Comparison
Compare FTAIM & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
FTAIM
FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares
Current Price
Current Price
Company Overview
Basic Information| Metric | FTAIM | FBIO |
|---|---|---|
| Founded | N/A | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Corporate Leasing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 90.7M |
| IPO Year | 2014 | 2011 |
Fundamental Metrics
Financial Performance| Metric | FTAIM | FBIO |
|---|---|---|
| Price | $27.12 | $2.55 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $17.00 |
| AVG Volume (30 Days) | 1.3K | ★ 302.2K |
| Earning Date | N/A | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1537.50 | 97.40 |
| EPS | 2.42 | ★ 2.86 |
| Revenue | ★ $2,507,409,000.00 | $63,262,000.00 |
| Revenue This Year | N/A | $55.22 |
| Revenue Next Year | N/A | $40.55 |
| P/E Ratio | $11.20 | ★ $0.88 |
| Revenue Growth | ★ 44.53 | 9.69 |
| 52 Week Low | $26.31 | $2.18 |
| 52 Week High | $27.81 | $4.53 |
Technical Indicators
Market Signals| Indicator | FTAIM | FBIO |
|---|---|---|
| Relative Strength Index (RSI) | 39.47 | 38.36 |
| Support Level | $26.85 | $2.19 |
| Resistance Level | $27.39 | $3.02 |
| Average True Range (ATR) | 0.08 | 0.09 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 22.50 | 33.53 |
Price Performance
Historical ComparisonAbout FTAIM FTAI Aviation Ltd. 9.500% Fixed-Rate Reset Series D Cumulative Perpetual Redeemable Preferred Shares
FTAI Aviation Ltd is an independent engine maintenance platform focused on the CFM56-5B, CFM56-7B, and V2500 aircraft engines, which power the 737NG and A320ceo aircraft. The company repairs and rebuilds engines in its maintenance facilities and with joint venture partners, and sells or leases engines through its proprietary Maintenance, Repair and Exchange (MRE) model under the Aerospace Products segment, which earns maximum revenue from North America and develops, repairs/refurbishes, and sells aircraft engines and aftermarket components. It also operates an Aviation Leasing segment, owning and managing a portfolio of on- and off-lease aircraft and engines, including engine transfers for rebuilding and sales.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.